Background: Triple-negative breast cancer (TNBC), as a highly aggressive and metastatic
tumor, can still not contain the medical needs. It has become an urgent problem to develop …

Background This study aimed to evaluate the expression status and prognostic role of
various immunoregulatory cells and test in triple-negative breast cancer (TNBC). Methods …

Purpose Stromal tumor-infiltrating lymphocytes (TILs) are independent prognostic factors in
systemically untreated early-stage triple-negative breast cancer (TNBC). Other immune …

Objective Triple-negative breast cancer (TNBC) is a heterogeneous disease with poor
prognosis. Circulating tumor cells (CTCs) are a promising predictor for breast cancer …

Introduction The role of derived neutrophil-to-lymphocyte ratio (dNLR) in predicting the
prognosis of patients with triple-negative breast cancer (TNBC) has not been well studied …

Background The clinical validity of circulating tumor cells (CTCs) is still controversial in
patients with triple-negative breast cancer (TNBC). Methods A comprehensive literature …

Objective This study aimed to investigate the prognostic value of lymph node ratio (LNR),
number of removed lymph nodes (RLNs), and number of negative lymph nodes (NLNs) in …

Triple-negative breast cancer (TNBC) with high tumour-infiltrating lymphocytes (TILs) has
been associated with a promising prognosis. To better understand the prognostic value of …

Purpose Triple-negative breast cancer (TNBC) has been associated with worse prognosis,
and biomarkers are needed to identify high-risk patients who may benefit from clinical trials …

The anti-tumor immune response was recently reported to play a critical role in the
chemotherapeutic sensitivity of breast cancer. Therefore, we investigated the correlation …